Journal of Plant Physiology
Ward for technical assistance with human specimen processing and routine clinical diagnostic testing
There were several factors varying between our patient and the other cases, particularly our patient also taking an SGLT2 inhibitor, but our case may suggest greater risk of EKA for a patient on synergistic regimens, Louwagie says
The types of adverse events seen in TRIUMPH-1 were generally consistent with trials of other incretin-based therapies
However, overlapping primary studies were predominantly concentrated in a limited number of large-scale, frequently cited RCTs in the field of GLP-1 RAs-such as LEADER, SUSTAIN, EXSCEL, HARMONY Outcomes, REWIND, ELIXA, SELECT, PIONEER, AWARD, AMPLITUDE, LEAD, SCALE, and STEP